X3 Acquisition (XCBE) Stock Analysis & Price (Updated Oct 15, 2026, 4:00 PM ET)
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $10.04, +0.00% vs the prior close of $10.04.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
XCBE ends flat (+0.0%) to $10.04, 3 down days in a row. Closed at $10.04, +0.00% vs the prior close of $10.04. Day range $10.04β$10.04, opened at $10.04.
XCBE daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 β XCBE ends flat (+0.0%) to $10.04, 3 down days in a row
- Closed at $10.04, +0.00% vs the prior close of $10.04. Day range $10.04β$10.04, opened at $10.04.
- Price is +0.3% vs its 50-day average ($10.01).
- 52-week range $9.75β$10.04; today's close sits at 100% of that range, at a new 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 β XCBE ends flat (+0.0%) to $10.04
- Closed at $10.04, +0.00% vs the prior close of $10.04. Day range $10.04β$10.04, opened at $10.04.
- Price is +0.4% vs its 50-day average ($10.00).
- 52-week range $9.75β$10.04; today's close sits at 100% of that range, at a new 52-week high.
Oct 13, 2026 β XCBE ends flat (+0.0%) to $10.04
- Closed at $10.04, +0.00% vs the prior close of $10.04. Day range $10.04β$10.04, opened at $10.04.
- Volume was 4.90K shares, 0.2x its 50-day average of 27.77K β lighter than usual.
- Price is +0.4% vs its 50-day average ($10.00).
- 52-week range $9.75β$10.04; today's close sits at 100% of that range, at a new 52-week high.
Oct 12, 2026 β XCBE ends flat (+0.1%) to $10.04, a 6-month high
- Closed at $10.04, +0.10% vs the prior close of $10.03. Day range $10.04β$10.04, opened at $10.04.
- Volume was 100 shares, 0.0x its 50-day average of 28.45K β lighter than usual.
- Price is +0.4% vs its 50-day average ($10.00).
- 52-week range $9.75β$10.04; today's close sits at 100% of that range, at a new 52-week high.
Oct 9, 2026 β XCBE ends flat (+0.0%) to $10.03
- Closed at $10.03, +0.00% vs the prior close of $10.03. Day range $10.03β$10.03, opened at $10.03.
- Price is +0.3% vs its 50-day average ($10.00).
- 52-week range $9.75β$10.03; today's close sits at 100% of that range, at a new 52-week high.
Oct 8, 2026 β XCBE ends flat (+0.1%) to $10.03 on 3.5x normal volume
- Closed at $10.03, +0.10% vs the prior close of $10.02. Day range $10.03β$10.03, opened at $10.03.
- Volume was 94.20K shares, 3.5x its 50-day average of 26.98K β unusually heavy trading.
- Price is +0.3% vs its 50-day average ($10.00).
- 52-week range $9.75β$10.03; today's close sits at 100% of that range, at a new 52-week high.
Oct 7, 2026 β XCBE ends flat (+0.0%) to $10.02, 6 down days in a row
- Closed at $10.02, +0.00% vs the prior close of $10.02. Day range $10.02β$10.02, opened at $10.02.
- Price is +0.2% vs its 50-day average ($10.00).
- 52-week range $9.75β$10.03; today's close sits at 96% of that range, 0.1% below the 52-week high.
- That makes 6 straight losses.
Oct 6, 2026 β XCBE ends flat (+0.0%) to $10.02 on 2.8x normal volume
- Closed at $10.02, +0.00% vs the prior close of $10.02. Day range $10.01β$10.02, opened at $10.02.
- Volume was 75.10K shares, 2.8x its 50-day average of 27.27K β unusually heavy trading.
- Price is +0.3% vs its 50-day average ($9.99).
- 52-week range $9.75β$10.03; today's close sits at 96% of that range, 0.1% below the 52-week high.
- That makes 5 straight losses.
Oct 5, 2026 β XCBE ends flat (+0.0%) to $10.02, 4 down days in a row
- Closed at $10.02, +0.00% vs the prior close of $10.02. Day range $10.02β$10.02, opened at $10.02.
- Price is +0.3% vs its 50-day average ($9.99).
- 52-week range $9.75β$10.03; today's close sits at 96% of that range, 0.1% below the 52-week high.
- That makes 4 straight losses.
Oct 2, 2026 β XCBE ends flat (-0.1%) to $10.02, 3 down days in a row
- Closed at $10.02, -0.10% vs the prior close of $10.03. Day range $10.01β$10.02, opened at $10.01.
- Volume was 68.40K shares, 1.7x its 50-day average of 39.30K.
- Price is +0.3% vs its 50-day average ($9.99).
- 52-week range $9.75β$10.03; today's close sits at 96% of that range, 0.1% below the 52-week high.
- That makes 3 straight losses.
XCBE latest news & SEC filings
Every SEC filing by or about XCBE in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 14, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: $1.84M
Aug 14, 2026 Β· Form SCHEDULE 13G/A β Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade XCBE
- How much it moves: over the last 20 sessions the average daily move was 0.02% (largest 0.1%). That is a relatively calm stock.
- Liquidity: about 15.83K shares (β$158.93K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $10.04 vs a range of $9.75β$10.04 (100% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 10-Q Aug 14, 2026; 10-Q May 20, 2026; 10-K Mar 25, 2026.
- Listing: Nasdaq Β· industry: Blank Checks.
XCBE market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 10.04 | 10.04 | 10.04 | 10.04 | 0 |
| Oct 14, 2026 | 10.04 | 10.04 | 10.04 | 10.04 | 0 |
| Oct 13, 2026 | 10.04 | 10.04 | 10.04 | 10.04 | 4.90K |
| Oct 12, 2026 | 10.04 | 10.04 | 10.04 | 10.04 | 100 |
| Oct 9, 2026 | 10.03 | 10.03 | 10.03 | 10.03 | 0 |
| Oct 8, 2026 | 10.03 | 10.03 | 10.03 | 10.03 | 94.20K |
| Oct 7, 2026 | 10.02 | 10.02 | 10.02 | 10.02 | 0 |
| Oct 6, 2026 | 10.02 | 10.02 | 10.01 | 10.02 | 75.10K |
| Oct 5, 2026 | 10.02 | 10.02 | 10.02 | 10.02 | 0 |
| Oct 2, 2026 | 10.01 | 10.02 | 10.01 | 10.02 | 68.40K |
| Oct 1, 2026 | 10.03 | 10.03 | 10.03 | 10.03 | 0 |
| Sep 30, 2026 | 10.03 | 10.03 | 10.03 | 10.03 | 0 |
| Sep 29, 2026 | 10.03 | 10.03 | 10.03 | 10.03 | 800 |
| Sep 28, 2026 | 10.02 | 10.02 | 10.02 | 10.02 | 700 |
| Sep 25, 2026 | 10.01 | 10.01 | 10.01 | 10.01 | 600 |
| Sep 24, 2026 | 10.01 | 10.01 | 10.01 | 10.01 | 28.60K |
| Sep 23, 2026 | 10.01 | 10.01 | 10.01 | 10.01 | 0 |
| Sep 22, 2026 | 10.01 | 10.02 | 10.01 | 10.01 | 30.40K |
| Sep 21, 2026 | 10.01 | 10.01 | 10.01 | 10.01 | 0 |
| Sep 18, 2026 | 10.01 | 10.01 | 10.01 | 10.01 | 12.80K |
About X3 Acquisition
X3 Acquisition (XCBE) is listed on the Nasdaq and classified by the SEC under βBlank Checksβ. Its business address is in MINNEAPOLIS, MN. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 2083493.
XCBE board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Christopher Joseph Bemis | Executive Vice President | Jan 21, 2026 |
| William Nelson Goetzmann | Director | Jan 21, 2026 |
| David H Lui | Director | Jan 21, 2026 |
| Hudson Toby George Orlando Maitland | Head of Capital Markets | Jan 21, 2026 |
| Andrew Redleaf | Chairman and CEO | Jan 22, 2026 |
| Nicholas Higgin Smith | Director | Jan 21, 2026 |
| Gillern Jeffry H. Von | Director | Jan 21, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Christopher Joseph Bemis | Executive Vice President | Jan 21, 2026 |
| Hudson Toby George Orlando Maitland | Head of Capital Markets | Jan 21, 2026 |
| Andrew Redleaf | Chairman and CEO | Jan 22, 2026 |
| Kenneth Weiller | COO and CFO | Jan 21, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
XCBE financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $229.72M, total liabilities $5.85M, cash $β (as of Jun 30, 2026).
XCBE earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks Β· Blank Checks
Southport Acquisition Corp. II (PORT-UN)Bold Eagle Acquisition (BEAG)Innventure (INV)Live Oak Acquisition Corp. VI (LOVIU)Pine Tree Acquisition (PAXGU)Frazier Life Sciences Acquisition Corp. II (FLSC)Archimedes Tech SPAC Partners II (ATII)Bluerock Acquisition Corp. II (BRRKU)EQV Ventures Acquisition Corp. II (EVAC)Pyrophyte Acquisition Corp. II (PAII)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on XCBE
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.